Found: 61
Select item for more details and to access through your institution.
Long Prime–Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 587, doi. 10.3390/vaccines12060587
- By:
- Publication type:
- Article
Myeloablative Chemotherapy with Autologous Stem Cell Transplant for Desmoplastic Small Round Cell Tumor.
- Published in:
- Sarcoma, 2015, v. 2015, p. 1, doi. 10.1155/2015/269197
- By:
- Publication type:
- Article
Neuroblastoma: A Disease Requiring a Multitude of Imaging Studies.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 7, p. 1172
- By:
- Publication type:
- Article
Radioimmunodetection of Neuroblastoma with Iodine-131-3F8: Correlation with Biopsy, Iodine-131-Metaiodobenzylguanidine and Standard Diagnostic Modalities.
- Published in:
- Journal of Nuclear Medicine, 1991, v. 32, n. 5, p. 769
- By:
- Publication type:
- Article
Second malignancies after childhood Hodgkin's disease: The memorial sloan-kettering cancer center experience.
- Published in:
- Cancer (0008543X), 1988, v. 62, n. 7, p. 1364, doi. 10.1002/1097-0142(19881001)62:7<1364::AID-CNCR2820620721>3.0.CO;2-T
- By:
- Publication type:
- Article
Familial neuroblastoma. Case reports, literature review, and etiologic considerations.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Metastatic neuroblastoma and testicular involvement.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Outpatient administration of naxitamab in combination with granulocyte‐macrophage colony‐stimulating factor in patients with refractory and/or relapsed high‐risk neuroblastoma: Management of adverse events.
- Published in:
- Cancer Reports, 2023, v. 6, n. 1, p. 1, doi. 10.1002/cnr2.1627
- By:
- Publication type:
- Article
Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01383-4
- By:
- Publication type:
- Article
Arsenic Trioxide as a Radiation Sensitizer for <sup>131</sup>I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 2, p. 231, doi. 10.2967/jnumed.115.161752
- By:
- Publication type:
- Article
Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1106597
- By:
- Publication type:
- Article
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Ovarian function in female survivors of high‐risk neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 9, p. 1, doi. 10.1002/pbc.31181
- By:
- Publication type:
- Article
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 2, p. 1, doi. 10.1002/pbc.30075
- By:
- Publication type:
- Article
Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Re‐thinking transplant for neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 6, p. 1, doi. 10.1002/pbc.28961
- By:
- Publication type:
- Article
Mandibular metastases in neuroblastoma: Outcomes and dental sequelae.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28918
- By:
- Publication type:
- Article
Reduced‐dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2020, v. 67, n. 9, p. 1, doi. 10.1002/pbc.28364
- By:
- Publication type:
- Article
Treatment and revaccination of children with paraneoplastic opsoclonus‐myoclonus‐ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.
- Published in:
- Pediatric Blood & Cancer, 2020, v. 67, n. 8, p. 1, doi. 10.1002/pbc.28319
- By:
- Publication type:
- Article
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dose-escalation is needed for gross disease in high-risk neuroblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 3, p. 469, doi. 10.1002/pbc.23132
- By:
- Publication type:
- Article
Osteochondroma in long-term survivors of high-risk neuroblastoma.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 12, p. 2090, doi. 10.1002/cncr.29316
- By:
- Publication type:
- Article
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 13, p. 2050, doi. 10.1002/cncr.28687
- By:
- Publication type:
- Article
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-G<sub>D2</sub> 3F8 monoclonal antibody.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 15, p. 2789, doi. 10.1002/cncr.28137
- By:
- Publication type:
- Article
Ifosfamide, carboplatin, and etoposide for neuroblastoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 3, p. 665, doi. 10.1002/cncr.27783
- By:
- Publication type:
- Article
Differential Impact of High-Dose Cyclophosphamide, Topotecan, and Vincristine in Clinical Subsets of Patients With Chemoresistant Neuroblastoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 12, p. 3054, doi. 10.1002/cncr.25232
- By:
- Publication type:
- Article
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178593
- By:
- Publication type:
- Article
High-dose carboplatin-irinotecan-temozolomide: Treatment option for neuroblastoma resistant to topotecan.
- Published in:
- Pediatric Blood & Cancer, 2011, v. 56, n. 3, p. 403, doi. 10.1002/pbc.22855
- By:
- Publication type:
- Article
Hypothyroidism after <sup>131</sup>I-monoclonal antibody treatment of neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2010, v. 55, n. 1, p. 76, doi. 10.1002/pbc.22452
- By:
- Publication type:
- Article
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
- Published in:
- Pediatric Blood & Cancer, 2009, v. 53, n. 7, p. 1340, doi. 10.1002/pbc.22243
- By:
- Publication type:
- Article
Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2009, v. 53, n. 1, p. 17, doi. 10.1002/pbc.21931
- By:
- Publication type:
- Article
Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: Possible leukemogenic role of temozolomide.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 51, n. 4, p. 552, doi. 10.1002/pbc.21658
- By:
- Publication type:
- Article
Transient sialoadenitis: A complication of <sup>131</sup>I-metaiodobenzylguanidine therapy.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 50, n. 6, p. 1271, doi. 10.1002/pbc.21391
- By:
- Publication type:
- Article
Brain-sparing radiotherapy for neuroblastoma skull metastases.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 50, n. 6, p. 1163, doi. 10.1002/pbc.21384
- By:
- Publication type:
- Article
Induction for high-risk neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2007, v. 49, n. 3, p. 221, doi. 10.1002/pbc.21206
- By:
- Publication type:
- Article
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: Broad implications for immunotherapy.
- Published in:
- Pediatric Blood & Cancer, 2007, v. 48, n. 4, p. 430, doi. 10.1002/pbc.20765
- By:
- Publication type:
- Article
Exploiting the MIBG-avidity of neuroblastoma for staging and treatment.
- Published in:
- Pediatric Blood & Cancer, 2006, v. 47, n. 7, p. 863, doi. 10.1002/pbc.20821
- By:
- Publication type:
- Article
Liver involvement in neuroblastoma: The memorial Sloan-Kettering experience supports treatment reduction in young patients.
- Published in:
- Pediatric Blood & Cancer, 2006, v. 46, n. 3, p. 278, doi. 10.1002/pbc.20564
- By:
- Publication type:
- Article
Long-term complications in survivors of advanced stage neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2005, v. 45, n. 3, p. 324, doi. 10.1002/pbc.20331
- By:
- Publication type:
- Article
Treatment reduction for neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2004, v. 43, n. 6, p. 619, doi. 10.1002/pbc.20189
- By:
- Publication type:
- Article
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6265, doi. 10.3390/cancers13246265
- By:
- Publication type:
- Article
Treatment of Spinal Involvement in Neuroblastoma Patients.
- Published in:
- Pediatric Neurosurgery, 2003, v. 39, n. 6, p. 291, doi. 10.1159/000075256
- By:
- Publication type:
- Article
Stage 4N neuroblastoma before and during the era of anti‐G<sub>D2</sub> immunotherapy.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 12, p. 2019, doi. 10.1002/ijc.34693
- By:
- Publication type:
- Article
Immunotherapy with anti‐G<sub>D2</sub> monoclonal antibody in infants with high‐risk neuroblastoma.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 2, p. 259, doi. 10.1002/ijc.34233
- By:
- Publication type:
- Article
High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma.
- Published in:
- 1991
- By:
- Publication type:
- journal article